Sunlenca is a Kit in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences. The primary component is .
| Product ID | 61958-3002_e2f725c8-d250-42e1-bb62-249cf99bcb28 |
| NDC | 61958-3002 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sunlenca |
| Generic Name | Lenacapavir Sodium |
| Dosage Form | Kit |
| Marketing Start Date | 2022-12-22 |
| Marketing Category | NDA / |
| Application Number | NDA215973 |
| Labeler Name | Gilead Sciences |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2022-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 61958-3001 | Sunlenca | LENACAPAVIR SODIUM |
| 61958-3002 | Sunlenca | LENACAPAVIR SODIUM |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SUNLENCA 88823358 not registered Live/Pending |
Gilead Sciences Ireland UC 2020-03-05 |